본문으로 건너뛰기
← 뒤로

Tracheostomal recurrence in oral squamous cell carcinoma: a literature review.

1/5 보강
International journal of oral and maxillofacial surgery 2026
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
wide excision with pectoralis major myocutaneous flap reconstruction, followed by systemic therapy including nivolumab
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
This case underscores the importance of early detection, aggressive surgical management, and the potential contribution of immunotherapy in improving outcomes. Preventive measures during tracheostomy and vigilant surveillance are essential to minimize recurrence risk.

Wu CH, Su ZY, Kuo YH, Chang DH

📝 환자 설명용 한 줄

Tracheostomal recurrence is a rare but serious complication following temporary tracheostomy in oral cancer patients, with an estimated incidence of ∼1%.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Wu CH, Su ZY, et al. (2026). Tracheostomal recurrence in oral squamous cell carcinoma: a literature review.. International journal of oral and maxillofacial surgery. https://doi.org/10.1016/j.ijom.2026.03.017
MLA Wu CH, et al.. "Tracheostomal recurrence in oral squamous cell carcinoma: a literature review.." International journal of oral and maxillofacial surgery, 2026.
PMID 41927417

Abstract

Tracheostomal recurrence is a rare but serious complication following temporary tracheostomy in oral cancer patients, with an estimated incidence of ∼1%. It is typically associated with poor prognosis, as most patients succumb to disease within months of recurrence. This report concerns a 61-year-old male with advanced squamous cell carcinoma of the right retromolar trigone (pT4bN3b, American Joint Committee on Cancer, 8th edn). Following segmental mandibulectomy, modified radical neck dissection, and adjuvant chemoradiotherapy, the patient developed a squamous cell carcinoma recurrence at the previous tracheostomy site 5 months later. He underwent wide excision with pectoralis major myocutaneous flap reconstruction, followed by systemic therapy including nivolumab. At 5 years of follow-up, he remains disease-free with preserved daily activities. Unlike most reported cases, which are associated with dismal outcomes, our patient achieved long-term disease-free survival after multimodal salvage therapy. This case underscores the importance of early detection, aggressive surgical management, and the potential contribution of immunotherapy in improving outcomes. Preventive measures during tracheostomy and vigilant surveillance are essential to minimize recurrence risk.

같은 제1저자의 인용 많은 논문 (5)